Comparison of ALK, RET, and ROS1 Gene Fusion Detection by Next-Generation Sequencing, Fluorescence in situ Hybridization, and Immunohistochemistry in Non-Small Cell Lung Cancer

被引：0
|
作者：
Oran, A. [1 ]
Grubb, J. [1 ]
Lieberman, D. B. [1 ]
Sussman, R. T. [1 ]
Morrissette, J. [1 ]
Rosenbaum, J. N. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2017年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST104
引用
收藏
页码：1033 / 1033
页数：1
相关论文
共 50 条
  • [21] Detection of ROS1 Rearrangement Using Immunohistochemistry: Correlation With ROS1 Fusion Analysis by Fluorescence In Situ Hybridization
    Coffman, Brittany
    Hettinga, Ana
    Buehler, Karen
    Vasef, Mohammad
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S26 - S27
  • [22] Molecular and clinicopathological characteristics of Chinese non-small cell lung cancers with ROS1 gene fusions identified by next-generation sequencing
    Gao, Dongling
    Han, Yuchen
    Zhao, Zhihua
    Ou, Qiuxiang
    Tong, Xiaoling
    Zhao, Ruiying
    Dong, Nan
    Wu, Xue
    Li, Wencai
    Jiang, Guozhong
    CANCER RESEARCH, 2020, 80 (16)
  • [23] Comparison of nCounter, immunohistochemistry, RT-PCR and FISH to detect ALK, ROS1 and RET rearrangements in advanced non-small cell lung cancer (NSCLC)
    Teixido, Cristina
    Reguart, Noemi
    Gimenez-Capitan, Ana
    Molina-Vila, Miguel Angel
    Galvan, Patricia
    Rodriguez, Sonia
    Pare, Laia
    Viteri, Santiago
    Peg, Vicente
    Yeste, Zaira
    Vinolas, Nuria
    Rosell, Rafael
    Prat, Aleix
    CANCER RESEARCH, 2016, 76
  • [24] ALK, ROS1 and EGFR next-generation tyrosine kinase inhibitors in advanced non-small-cell lung cancer
    Winiarczyk, Kinga
    Piorek, Aleksandra
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2019, 15 (03): : 150 - 157
  • [25] The routine detection of ROS1 fusion rearrangement in non-small cell lung cancer
    Wu, J.
    Lin, Y.
    He, X.
    He, P.
    Fu, X.
    Gu, X.
    ANNALS OF ONCOLOGY, 2015, 26 : 9 - 9
  • [26] Fluorescence In Situ Hybridization and Immunohistochemistry as Diagnostic Methods for ALK Positive Non-Small Cell Lung Cancer Patients
    Martinez, Pablo
    Hernandez-Losa, Javier
    Angeles Montero, M.
    Cedres, Susana
    Castellvi, Josep
    Martinez-Marti, Alex
    Tallada, Natalia
    Murtra-Garrell, Nuria
    Navarro-Mendivill, Alejandro
    Rodriguez-Freixinos, Victor
    Canela, Mercedes
    Ramon y Cajal, Santiago
    Felip, Enriqueta
    PLOS ONE, 2013, 8 (01):
  • [27] ASSESSMENT OF ALK REARRANGEMENT IN ADVANCED NON-SMALL CELL LUNG CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION & IMMUNOHISTOCHEMISTRY
    Han, X.
    Ma, L.
    Liu, Y.
    Zhang, N. N.
    Li, D.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 390 - 390
  • [28] Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma
    Febres-Aldana, Christopher A.
    Chang, Jason C.
    Jungbluth, Achim A.
    Adusumilli, Prasad S.
    Bodd, Francis M.
    Frosina, Denise
    Geronimo, Jerica A.
    Hernandez, Enmily
    Irawan, Helen
    Offin, Michael D.
    Rekhtman, Natasha
    Travis, William D.
    Vanderbilt, Chad
    Zauderer, Marjorie G.
    Zhang, Yanming
    Ladanyi, Marc
    Yang, Soo-Ryum
    Sauter, Jennifer L.
    MODERN PATHOLOGY, 2024, 37 (03)
  • [29] Simultaneous Detection of Gene Rearrangements and Variants in Non-Small Cell Lung Cancer by Next-Generation Sequencing
    Xu, Shuo
    Boag, Alexander
    Mates, Mihaela
    Chen, Lina
    Feilotter, Harriet
    MODERN PATHOLOGY, 2016, 29 : 487A - 487A
  • [30] Simultaneous Detection of Gene Rearrangements and Variants in Non-Small Cell Lung Cancer by Next-Generation Sequencing
    Xu, Shuo
    Boag, Alexander
    Mates, Mihaela
    Chen, Lina
    Feilotter, Harriet
    LABORATORY INVESTIGATION, 2016, 96 : 487A - 487A
12345